Location History:
- Cambridge, MA (US) (2006)
- Palo Alto, CA (US) (2006)
Company Filing History:
Years Active: 2006
Title: Innovations of Ningning Miao
Introduction
Ningning Miao is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biotechnology, particularly in the area of embryonic development and neuronal survival. With a total of 2 patents, Miao's work has the potential to impact therapeutic approaches for various neurological disorders.
Latest Patents
Miao's latest patents include "Vertebrate embryonic patterning-inducing proteins, compositions and uses related thereto." This patent reveals that hedgehog proteins possess novel activities beyond phenotype specification. Research using cultures derived from the embryonic day 14.5 (E14.5) rat ventral mesencephalon demonstrates that hedgehog proteins are trophic for dopaminergic neurons. Notably, hedgehog not only promotes the survival of dopaminergic neurons but also supports the survival of midbrain GABA-immunoreactive (GABA-ir) neurons. Another significant patent is the "Method of treating dopaminergic and GABA-nergic disorders," which further explores the therapeutic potential of hedgehog proteins in treating neurological conditions.
Career Highlights
Miao is currently employed at Curis, Inc., a company known for its innovative approaches in drug development. His work at Curis has allowed him to focus on groundbreaking research that bridges the gap between basic science and clinical applications.
Collaborations
Miao collaborates with talented individuals such as Monica Wang and Nagesh K Mahanthappa. These collaborations enhance the research environment and foster innovative solutions in their respective fields.
Conclusion
Ningning Miao's contributions to biotechnology and his innovative patents highlight his role as a leading inventor in the field. His research on hedgehog proteins opens new avenues for treating neurological disorders, showcasing the importance of innovation in science.